Your browser doesn't support javascript.
loading
Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma.
Merryman, Reid W; Edwin, Natasha; Redd, Robert; Bsat, Jad; Chase, Matthew; LaCasce, Ann; Freedman, Arnold; Jacobson, Caron; Fisher, David; Ng, Samuel; Crombie, Jennifer; Kim, Austin; Odejide, Oreofe; Davids, Matthew S; Brown, Jennifer R; Jacene, Heather; Cashen, Amanda; Bartlett, Nancy L; Mehta-Shah, Neha; Ghobadi, Armin; Kahl, Brad; Joyce, Robin; Armand, Philippe; Jacobsen, Eric.
Afiliação
  • Merryman RW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Edwin N; Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO.
  • Redd R; Department of Biostatistics, Dana-Farber Cancer Institute, Boston, MA.
  • Bsat J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Chase M; Department of Medicine, Brigham and Women's Hospital, Boston, MA.
  • LaCasce A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Freedman A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Jacobson C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Fisher D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Ng S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Crombie J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Kim A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Odejide O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Jacene H; Department of Imaging, Dana-Farber Cancer Institute, Boston, MA; and.
  • Cashen A; Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO.
  • Bartlett NL; Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO.
  • Mehta-Shah N; Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO.
  • Ghobadi A; Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO.
  • Kahl B; Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO.
  • Joyce R; Division of Hematology, Beth Israel Deaconess Medical Center, Boston, MA.
  • Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Jacobsen E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Blood Adv ; 4(5): 858-867, 2020 03 10.
Article em En | MEDLINE | ID: mdl-32126141
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Linfoma de Célula do Manto Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Linfoma de Célula do Manto Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article